use
pseudomonas
aeruginosa
vaccine
pateints
acute
leukemia
cystic
fibrosis
heptavalent
lipopolysaccharide
pseudomonas
vaccine
evaluated
patient
acute
leukemia
patient
cystic
fibrosis
month
interval
clinical
center
national
institute
health
patient
excellent
serum
hemagglutinating
ha
antibody
response
immunization
comparison
patient
cystic
fibrosis
patient
leukemia
smaller
ha
antibody
response
lasted
shorter
period
time
also
experienced
greater
toxicity
vaccine
mixing
adrenal
corticosteroid
vaccine
greatly
decreased
side
reaction
among
patient
leukemia
without
significantly
inhibiting
antibody
production
previous
antineoplastic
chemotherapy
little
influence
antibody
response
patient
leukemia
exception
methortrexate
vaccinated
patient
leukemia
pseudomonas
infection
bacterial
fungal
infection
whereas
pseudomonas
infection
bacterial
fungal
infection
occurred
control
group
patient
acute
leukemia
patient
cystic
fibrosis
pseudomonas
infection
vaccination
